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Abstract: Alcohol consumption and its abuse is a major health problem resulting in 
significant healthcare cost in the United States. Chronic alcoholism results in damage to 
most of the vital organs in the human body. Among the alcohol-induced injuries, alcoholic 
liver disease is one of the most prevalent in the United States. Remarkably, ethanol alters 
expression of a wide variety of microRNAs that can regulate alcohol-induced complications 
or dysfunctions. In this review, we will discuss the role of microRNAs in alcoholic 
pancreatitis, alcohol-induced liver damage, intestinal epithelial barrier dysfunction, and 
brain damage including altered hippocampus structure and function, and neuronal loss, 
alcoholic cardiomyopathy, and muscle damage. Further, we have reviewed the role of 
altered microRNAs in the circulation, teratogenic effects of alcohol, and during maternal or 
paternal alcohol consumption. 
Keywords: alcoholism; miRNA; lncRNA; teratogen; alcoholic liver disease;  
alcoholic pancreatitis 
 
1. Introduction to microRNA 
MicroRNAs act to fine-tune the expression of a vast number of genes and regulate cell physiology 
and pathology. MicroRNAs are endogenous 19–23 nucleotide, small non-coding RNAs that modulate 
mRNA levels through decreased transcription or post-transcriptionally induced mRNA decay. The 
processing of microRNA was well described before [1,2]. Briefly, microRNA is mostly produced  
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from RNA polymerase II transcribed genes in the nucleus; recently it has also been shown that  
RNA polymerase III can transcribe certain primary microRNAs (pri-microRNA). Pri-microRNA 
transcripts produced by RNA polymerase II are 5' capped and 3' poly-adenylated in the nucleus.  
Pri-microRNA is then cleaved and processed by the RNase III enzyme, Drosha-DGCR8 (DiGeorge 
syndrome critical region 8), a microprocessor complex which results in ~70 nucleotide stem loop 
precursor microRNA (pre-microRNA). The pre-microRNA is exported from the nucleus to the 
cytoplasm by RanGTP-dependent dsRNA transport protein or exportin 5 [3]. Cytoplasmic RNase III 
enzyme, Dicer, in conjunction with TAR RNA-binding protein 2 binds to the pre-microRNA and 
cleaves the terminal loop. The remaining duplex microRNA interacts with Argonaute protein and only 
one of the duplex strands (lead strand) binds to form microRNA-induced silencing complex. The other 
passenger strand is mostly degraded in the cytoplasm. 
MicroRNAs play a role in many different physiological and pathophysiological states including  
in alcoholic liver disease (ALD) [4] and microRNAs were suggested to be a master regulator of  
ethanol-induced multi-organ injury [5]. In this review, we will present mechanisms of alcohol-induced 
damage to vital organs like pancreas, liver, intestine, brain, and heart as shown in the Figure 1. 
Additionally, we will present evidence for a role of altered microRNAs in the vital organ dysfunction 
caused by acute or chronic alcohol consumption. 
 
Figure 1. Ethanol Induces Damage to Vital Organs in the Human Body. Ethanol consumption 
induces liver cells to accumulate lipid droplets and predisposes to alcoholic steatohepatitis, 
cirrhosis and increases the risk for the development hepatocellular carcinoma. In the pancreas, 
chronic alcohol consumption results in pancreatitis and pancreatic fibrosis. In the intestine, 
ethanol induces epithelial barrier dysfunction and gram negative bacterial overgrowth 
resulting in an enhanced production of LPS for the pathogenesis of alcoholic liver injury. 
Ethanol also produces brain damage by altering hippocampus structure and function and 
neuronal loss. Chronic ethanol consumption also causes alcoholic cardiomyopathy and 
cardiac arrhythmias. Additionally, alcohol has been shown to act as a teratogenic agent and 
epigenetic modulator via altering non-coding RNA levels such as microRNA and lncRNAs. 
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2. Alcohol Metabolism and Pancreatitis 
Alcohol is mostly metabolized in the liver by the enzymes, alcohol dehydrogenase, acetaldehyde 
dehydrogenase and microsomal cytochrome p450-2E1 oxidase (CYP2E1). Alcohol metabolism leads 
to the generation of toxic metabolite, acetaldehyde, which reacts to various proteins to form 
acetaldehyde adducts resulting in improper protein functions [6]. Alcohol metabolism also results in an 
increased production of reactive oxygen species (ROS) through CYP2E1. Enhanced production of 
ROS initiates peroxidation of cellular lipids including fatty acids present in the cytoplasm and 
membranes [7]. Inhibition of CYP2E1 or CYP2E1 knockout in mice protects against ethanol-induced 
liver damage in rodent models [7]. However, inhibition of alcohol metabolism resulted in an increase 
in non-oxidative ethanol metabolites like fatty acid ethyl ester (FAEE) and phosphatidyl ethanol [8,9]. 
Increased levels of FAEE and phosphatidyl ethanol have been shown to directly correlate with 
alcoholic pancreatic injury and pancreatitis [8,9]. Recently, inhibition of FAEE synthase was shown to 
ameliorate ethanol-induced inflammation and acute pancreatic damage [9]. Ethanol exposed hepatoma 
cells, HepG2 were also shown to secrete increased amount of FAEE in to the medium in association 
with high density lipoproteins [10]. Chronic alcoholics have an increased level of FAEE in their hair 
and systemic circulation [11]. Increased FAEE accumulates in the pancreas for the initiation of 
acute pancreatic injury [8,9]. Increased FAEE has also been shown to affect intestinal epithelial 
barrier function by disrupting the tight junctions through ROS-dependent mechanisms [12]. 
Altered microRNAs in Alcoholic Pancreatitis 
Prolonged ethanol consumption induces alcoholic pancreatitis and pancreatic fibrosis [13–15]. 
Ethanol activates pancreatic stellate cells to produce pro-fibrogenic mediators like transforming growth 
factor- (TGF-) and platelet-derived growth factor, and extracellular matrix proteins for the initiation 
of pancreatic fibrosis and alcoholic pancreatitis [16,17]. Antioxidants like vitamin E were shown to 
prevent alcohol-induced pancreatitis in rodents [16]. Chronic ethanol feeding to mice induces an 
increase in the expression of miR-21, miR-199a-3p and miR-211 and down regulated miR-148a and 
miR-802 in the pancreas [18]. Similar changes in microRNAs were also noted in pancreatic stellate 
cells isolated from ethanol fed mice [18]. Further, increased miR-21 was suggested to regulate 
connective tissue growth factor as a positive feedback loop in chronic pancreatitis, where increased  
miR-21 increased connective tissue growth factors levels [18,19]. Ethanol was also shown to induce 
the expression of connective tissue growth factor in human hepatic stellate cells [20]. Together, 
microRNAs are involved in the activation of pancreatic stellate cells during alcoholic pancreatitis and 
pancreatic fibrosis. Further studies are needed to elucidate whether a miR-21 inhibitor can prevent 
alcoholic pancreatitis and pancreatic fibrosis. 
3. Circulating microRNAs in ALD 
Circulating microRNAs have been studied as biomarkers for ALD. Emerging evidence has shown 
that microRNAs are stable in circulation and they are also resistant to circulating RNases that are 
abundant in blood [21]. It was earlier thought that circulating microRNAs are only released along with 
microvesicles or exosomes providing RNase protection. But recent studies have shown that many 
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ribonucleoprotein complexes like nucelophosmin-1, argonaute1 and 2-bound microRNAs were released 
in to the blood and these RNA-binding proteins protect extracellular degradation of microRNAs [22–26]. 
Rats fed an ethanol diet showed increased circulating levels of miR-122 and miR-155 in exosomes [27]. 
Ethanol-induced increase in circulating miR-122 was abolished in toll-like receptor 4 (TLR4) and 
NADPH oxidase knockout mice suggesting a critical role for TLR4 and NADPH oxidase in the release 
of miR-122 [27]. 
Circulating miR-122 was suggested as a biomarker for liver injury similar to serum ALT and not as 
a marker for disease progression. However, circulating microRNAs that are upregulated in ALD were 
also found to be increased in other liver diseases like drug-induced liver toxicity and non-alcoholic 
fatty liver disease [28]. An animal model of alcoholic steatohepatitis showed 25 different microRNAs 
were upregulated in the circulation and seven microRNAs were down regulated. Among these only 
four of them (miR-185, miR199a-3p, miR-214 and miR-490) were shown to be similarly altered in 
liver tissue and circulation [29]. This suggests that circulating microRNAs are not solely from liver 
damage; another major source of circulating microRNAs was blood cells [30,31]. A recent analysis of 
patients with diabetes showed that there was a difference in the levels of circulating microRNAs 
between platelet-rich plasma and platelet-poor plasma suggesting that platelets are substantial 
contributors of microRNA in the circulation [32,33]. An epidemiological study has shown that alcohol 
consumption was inversely associated with platelet activation and aggregation [34]. Further studies are 
needed to elucidate the role of platelet microRNAs in ALD. 
3.1. Ethanol Alters Monocyte Function via Circulating microRNAs 
Patients with ALD show elevated levels of plasma IL-17 and CCL2. IL-17 is an inflammation-promoting 
cytokine and CCL2 is a chemotactic protein that help attracts monocytes to the site of inflammation [35–37]. 
Chronic alcoholics also had elevated levels of IL-17-producing T-helper lymphocytes. Hepatic stellate 
cells have the receptor for IL-17 and increased IL-17-producing T-helper lymphocytes were suggested 
to be recruited to the liver from the circulation in patients with chronic alcoholism [37–39]. Binge alcohol 
consumption was recently shown to increase exosomal miR-122 and miR-155 in the circulation [39]. 
Further, primary hepatocytes also showed an increase in the release of miR-122-containing exosomes [39]. 
Exosomes-isolated from hepatocytes were added to the human monocyte-derived cell line, THP-1, 
along with LPS to mimic ALD patient’s circulation [39]. Hepatocyte exosomes plus LPS treatment to 
monocytes increased cytokine and chemokine levels such as TNF-, IL1-, and CCL2 [39]. These 
increased pro-inflammatory cytokines and chemokine levels due to the treatment of hepatocyte-exosomes 
were abolished with anti-sense miR-122 inhibitor treatment in the THP1 cells [39]. Clearly, circulating 
miR-122 derived from injured hepatocytes alters monocyte and T-helper lymphocyte function to 
promote inflammation in ALD. 
3.2. Ethanol Abuse and Bone Marrow Depression 
Alcoholism is a significant contributing factor for vitamins B1, B3, B6, B7, C, D and folate 
deficiency [40]. Chronic ethanol consumption has been shown to exert its toxic effect on bone marrow 
and results in the impairment of blood cell production or bone marrow depression. The vitamin 
deficiency further exacerbates the bone marrow depression [41]. Chronic alcohol consumption  
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was shown to damage red blood cell precursors and resulted in producing enlarged RBCs. Several 
studies have also reported macrocytosis (enlarged RBCs) and osteoporosis in chronic alcohol abuse 
patients [41–43]. Further, ethanol and acetaldehyde can directly inhibit the osteoblastogenic potential 
of the bone marrow and decreases bone formation [44]. Similarly, alcohol also increases bone  
mass degradation, density and negatively regulates bone microarchitecture [45]. Autologous bone 
marrow-derived stem cell transplantation was shown to improve liver function in patients with ALD 
and decompensated alcoholic cirrhosis in randomized clinical trials [46–48]. Together, chronic 
alcoholics develop an alcoholic bone disease and the potential therapeutics for this toxic effect on bone 
marrow has been recently reviewed [42,49]. The role of microRNAs in bone-related disease has been 
reported. For example, miR-29a, miR-31, miR-133a, and miR-378 can modulate osteogenic 
differentiation of mesenchymal stem cells by targeting osteoclast-specific genes [50]. Additionally, 
circulating microRNAs like miR-328-3p, let-7g-5p were shown to be decreased with osteoporotic bone 
fracture [51]. However, the role of microRNAs in bone marrow depression during alcoholism or ALD 
has not been studied and needs further investigation. 
3.3. Pitfalls of Circulating microRNA Analysis 
Circulating microRNAs have been proposed to serve as a biomarker and prognostic marker for 
alcoholism, ALD and alcoholic steatohepatitis [29,52]. Also, circulating microRNAs were suggested to 
be a blood marker for liver inflammation, fibrosis and cancer detection [53,54]. However, there are 
potential pitfalls of measuring microRNAs in the circulation. As discussed above the role of blood cell 
microRNA changes during alcoholism need to be considered. Another pitfall is that candidates for use 
in microRNA normalization, for example, small nuclear and small nucleolar RNAs like RNU4, RNU6b 
(U6) and RNU48 were highly variable in healthy populations [55]. Notably, U6 is downregulated in 
the serum of patients with liver fibrosis [56]. In contrast, U6 levels in the circulation were upregulated 
in patients with critical illness and sepsis [56]. The use of miR-16 as an internal control for circulating 
microRNAs has also been reported [57]. However, miR-16 and miR-15b levels were shown to be 
susceptible to hemolysis of blood samples [56,57]. Avoiding several technical variability factors like 
isolation procedures, storage, multiple freeze-thaw cycles of a sample and the use of an appropriate 
amount of sample and enzymatic reactions were suggested to minimize variations and difference [55]. 
For example, a report showed that low GC content microRNAs were lost in the extraction protocol, 
when a small number of cells were used compared to a high number of cells [58]. Additionally, spiking 
of non-human microRNAs like Caenorhabditis elegans cel-miR-67 as an external control during RNA 
extraction, cDNA synthesis, and PCR amplification were suggested to be helpful to track the loss of 
microRNAs during extraction and processing [59]. For internal control of circulating microRNA 
analysis, various strategies have been proposed in a case-by-case study [55]. From the analysis of healthy 
volunteers, it has been proposed that miR-24, miR-126, and miR-484 were stable microRNAs [55]. 
4. Liver microRNAs in Alcoholic Liver Disease 
Alcohol-induced liver damage includes a spectrum of complications like steatosis, alcoholic 
steatohepatitis, fibrosis, cirrhosis, and increased risk for hepatocellular carcinoma. MicroRNAs in the 
liver are regulated by exposure to an ethanol-containing diet [52,60]. Mice fed a Lieber-DeCarli 
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alcohol diet were studied for hepatic microRNA content as an initial screen for microRNAs that may 
be involved in ALD. Most microRNAs (~98%) were not altered, while approximately 1% were 
increased by alcohol feeding and 1% were decreased. The increased microRNAs include miR-320, 
miR-486, miR-705, and miR-1224. Decreased microRNAs were miR-27b, miR-182, miR-183,  
miR-199a-3p, miR-200a, miR-214, and miR-322 [61]. A separate study performed by gavage of 
alcohol by a gastrostomy tube found that ethanol increased miR-21, miR-34a, miR-137, miR-409-5p, 
miR-509-3p, and miR-882 and decreased levels of let-7 family members (let-7a, -7b, and -7g),  
miR-122, miR-127, miR-181a, miR-181b, miR-192, and miR-871 [62]. The lack of overlap in these 
microRNA sets is notable and may reflect the difference in a liquid ethanol-containing diet versus 
ethanol gavage. In addition, alcohol decreased the expression of miR-199 in human and rat liver 
sinusoidal endothelial cells [63]. Targets of miR-199 were endothelin-1 and HIF1, loss of miR-199 
expression increased endothelial HIF1 levels [63]. Increased HIF1 functions as a survival signal and 
induced lipid accumulation in alcoholic fatty liver disease [64] and has been reviewed before [65]. 
Patients with ALD, and animal models of ALD, have increased levels of hepatic and circulating 
tumor necrosis factor- (TNF-) [66–68]. In normal macrophages, it has been suggested that the  
3'-untranslated region of TNF- mRNA inhibits its own translation [69]. Alcohol also induced the 
expression of miR-155 and TNF- in Kupffer cells and macrophages [63,70]. Upregulation of miR-155 
in macrophages is via the activation of NFB [70]. Inhibition of miR-155 using anti-sense-miR-155 
prevented the production of TNF- in macrophages and further, miR-155 increased the half-life of  
TNF- mRNA [70]. Alternatively, ethanol induced the translational initiation and stabilization of  
TNF- mRNA by increasing the expression of AU-rich binding protein, HuR. Further, miR-132 and 
miR-155 were elevated in the isolated hepatocytes and Kupffer cells from alcohol fed animals [70]. 
MiR-132 targets NAD-dependent deacetylase, SIRT1 and p65 subunit of NFkB which can result in 
decreased NFkB activity [71]. Interestingly, a recent study showed that hepatocytes isolated from  
miR-155 knockout mice were resistant to Fas-induced apoptosis [72]. Myeloid cell leukemia-1 
(MCL1) was found to be upregulated in the ethanol-fed liver studied from miR-155 knockout mice, 
suggesting that MCL1 is a direct target of miR-155 [72]. Elevated levels of miR-155 after chronic 
ethanol could also function to induce apoptosis of hepatocytes and other liver cells in ALD [72,73]. 
Together, liver microRNAs are altered in ALD. 
Chronic alcohol feeding of mice showed upregulation of miR-33, miR-34a, and miR-217 in the liver 
and these microRNAs were also elevated in ethanol-exposed mouse AML-12 hepatocytes. Alcohol 
dehydrogenase, but not aldehyde dehydrogenase was found to be critical for the increased expression 
of miR-217. Further, SIRT1 was identified as a target gene for miR-217 in the liver. Ethanol treatment 
decreased the expression of SIRT1 and a similar decrease in SIRT1 was observed in hepatocytes 
transfected with miR-217 mimic [74]. Ethanol treatment of miR-217-transfected hepatocytes exacerbated 
the decrease in the levels of SIRT1 protein [74,75]. Downstream mediators of SIRT1 were SREBP-1 
(sterol regulatory element-binding protein 1) and peroxisome proliferator-activated receptor1-alpha 
(PGC-1) [75]. Loss of SIRT1 increased the level of acetylated SREBP-1 and acetylated PGC-1 for 
enhanced lipogenesis in the alcoholic liver and has been reviewed before [75]. Additionally, lipin-1,  
a phosphatidic acid phosphohydrolase, which converts phosphatic acid into diacyl glycerol was also 
found to be down-regulated by miR-217 [76]. In contrast, ethanol can directly induce the expression of 
lipin-1 in the liver via inhibition of AMP kinase and activation of SREBP-1 on the lipin-1 promoter [77]. 
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In ethanol fed mice, miR-33 and miR-34a were also increased, though not in cultured cells [74]. 
MiR-33 was found to decrease VLDL secretion by repressing N-ethylmaleimide sensitive factor,  
a protein involved in SNARE-dependent intracellular lipoprotein trafficking [78,79]. Importantly, 
ethanol feeding increased miR-33 expression and decreased VLDL secretion [4,79]. Defective VLDL 
secretion has been implicated in the pathogenesis of alcoholic hepatic steatosis [80]. 
4.1. Liver miR-34a in ALD 
MiR-34a is well known for its dual function as pro- and anti-apoptotic microRNA. Expression of 
miR-34a was found to be increased in hepatocytes and cholangiocytes with LPS plus ethanol exposure 
and in the livers of alcohol fed animals. Ethanol induced hypo methylation in the promoter regions of 
miR-34a thereby increasing its expression. Increased miR-34a was shown to target and represses 
caspase-2 and SIRT1 proteins [62]. This represents a second SIRT1-targeting microRNA that is 
elevated with ethanol feeding in rodents (miR-34a and miR-217). Here, increased miR-34a in the liver 
was suggested to promote survival of hepatocytes, hepatic stellate cells and cholangiocytes [62]. 
Ethanol was also shown to export SIRT1 from the nucleus to the cytoplasm. Ethanol-induced SIRT1 
nucleo-cytoplasmic shunting was suggested to be due to the generation of ROS and acetaldehyde,  
an ethanol metabolic byproduct [81]. SIRT1 is a redox sensitive enzyme and gets post-translational 
modifications with the exposure of oxidants and acetaldehydes resulting in decreased enzyme activity 
and undergoes proteasome degradation [82]. Further studies are needed to determine the exact role of 
SIRT1 and miR-34a in the progression of ALD. 
4.2. Role of miR-21 in ALD 
Liver regeneration and hepatocyte proliferation after 2/3 partial hepatectomy was shown to be 
dependent on miR-21. MiR-21 targets Btg2, a cell cycle inhibitor. Normally, Btg2 prevents the 
activation of forkhead box protein M1 (FoxM1), a protein important for hepatocyte DNA synthesis 
after partial hepatectomy [83]. Studies have shown that prolonged ethanol feeding enhanced miR-21 
expression in the liver [84,85]. Ethanol fed animals showed a dramatic increase in miR-21 12h after 
partial hepatectomy compared to control-fed animals [84]. Further, 5 weeks of ethanol (5% v/v) to 
mice was also shown to induce the levels miR-21 and miR-34a [85] and a similar increase miR-21 was 
also observed in the liver of patients with ALD [85]. 
Inhibition of miR-21 was well known to induce apoptosis in most cancer cells including ovarian cancer 
cells [86,87]. Overexpression of miR-21 in normal hepatocytes results in resistance to ethanol-induced 
apoptosis suggesting an important role for this microRNA [85]. The mechanism of miR-21 induction with 
ethanol exposure in the liver is via activation of IL-6/STAT3 signaling pathway [73,85]. Ethanol-induced 
activated STAT3 binds to the miR-21 promoter region for transcriptional up-regulation of miR-21 
primary transcripts [73,85]. Additionally, miR-21 was shown to target the 3' UTRs of FAS ligand G 
(FASLG) and death receptor 5 (DR5) [85]. Treatment of ethanol to primary hepatocytes, hepatic stellate 
cells and HepG2 cells was also shown to decrease the expression of FASLG and DR5 proteins via 
increasing miR-21 levels [85]. Together, miR-21 is induced with ethanol exposure via IL-6/STAT3 
signaling and targets extrinsic apoptotic mediators like FASLG and DR5 for the prevention of liver 
cell apoptosis and could favor liver regeneration in ALD. 
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5. Gut-Liver Axis in the Pathogenesis of ALD 
Alcohol consumption is well known to damage intestinal barrier function which results in the 
translocation of gut-derived lipopolysaccharide (LPS) into the portal and systemic circulation. LPS is  
a cell wall structural component of gram negative bacteria [39]. Source for LPS from the gut is due to 
the loss of tight junction proteins in the intestine epithelial cells. LPS can simply diffuse into 
circulation or can be transported through mesenteric lymph system from the intestine and enter into 
systemic circulation [88,89]. Hepatocytes and Kupffer cells in the liver remove LPS from the circulation 
or lymphatic system. Detoxification of LPS in the liver is compromised in ALD. Alcohol-induced 
increased LPS from the gut due to bacterial overgrowth results in LPS accumulation to other organs 
like spleen and brain in ALD [90,91]. Several studies have demonstrated that patients with chronic 
alcoholism have elevated levels of LPS in the systemic circulation [88–91]. In animal models of 
ethanol administration there is a 5–15 fold increase in LPS in the portal and systemic circulation [92]. 
Ethanol feeding was shown to shift the gut microbiome towards an increase in gram negative  
bacteria-dependent endotoxemia and increased intestinal permeability [93]. Metagenomic deep 
sequencing analysis of gut microbes in alcoholics further reveals that there was a significant increase 
in Alcaligenes genus, gram negative bacteria [93]. Intestinal Alcaligenes growth is ideal only in alkaline 
pH and it was found that alcohol feeding increases cecal pH, favoring Alcaligenes overgrowth [93]. 
Supplementation of non-absorbable antibiotics, dietary fiber, probiotics and saturated long-chain fatty 
acids (LCFA) was shown to prevent ethanol-induced intestinal bacterial translocation and decreased 
liver damage due to ethanol intoxication [93,94]. Supplementation of Lactobacillus GG also prevents 
loss of tight junction proteins in the intestine, endotoxemia and hepatic injury caused due to ethanol 
feeding to mice [94]. 
Intestinal bacteria ferment indigestible dietary fibers into short chain fatty acids (SCFA) and gut microbes 
also produce many nutrients (polyunsaturated fatty acids, gamma-amino butyric acid, histamine) and essential 
vitamins like vitamin B and vitamin K [95]. Chronic alcoholics show an increase in oral-to-cecal 
transit time which might help bacterial overgrowth and increases bacterial metabolites [95]. A recent 
metabolomics study in mice fed an ethanol diet for 8 weeks showed increased levels of acetic acid, an 
end product of ethanol metabolism [95]. In contrast, SCFAs like propionic acid, isobutyric acid, and 
butyric acid were decreased in ethanol-fed animals suggesting a loss of SCFA producing bacteria [95]. 
Butyrate, a SCFA is a well-known fuel for colonic epithelial cells [96]. Butyrate has also been shown 
to protect intestinal barrier by increasing the assembly of tight junction through several mechanisms 
including AMP kinase activation [96,97]. Ethanol-induced loss of butyrate production could alter the 
repair response for the intestinal barrier dysfunction. Further, decreased SCFAs with ethanol could also 
decrease immune-protective effect against bacterial infection in the gut [98]. In summary, ethanol-induced 
bacterial overgrowth, dysbiosis towards an increase in gram negative bacteria, endotoxemia, and 
intestinal permeability contributes to the pathogenesis of alcoholic liver injury. 
5.1. Altered Intestinal microRNAs in ALD 
The role of microRNA in the pathogenesis of intestinal injury with ethanol was reported. Here we 
will briefly discuss the functions of microRNAs that are altered with ethanol consumption. Chronic 
ethanol administration induces the expression of miR-155 in the intestine [73]. Similar to the effect 
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observed in the liver, ethanol-induced upregulation of miR-155 was shown to stabilize and increase  
the half-life of TNF- messenger RNA and its molecular target Reg3b [73]. Reg3b is a C-type lectin 
secreted into the intestinal lumen for its antimicrobial activity against gram negative bacteria to 
prevent bacterial translocation across the lumen [99]. Acute ethanol exposure was shown to increase 
the levels of Reg3b protein in the small bowel [73]. Post-translational modifications of Reg3b were 
suggested as a mechanism for increased Reg3b protein levels with acute ethanol exposure [85]. 
Recently, Reg3b Knockout mice were found to be more prone to gram negative bacterial infection [99]. 
Mice deficient in miR-155 did not show an increase in Reg3b protein levels with chronic ethanol 
exposure suggesting the role of Reg3b and miR-155 in alcohol-induced intestinal dysfunction [73]. 
MicroRNA-155 has been shown to be involved in inflammation, immunity and also in hematopoiesis [100]. 
MiR-155 was shown be increased in many diseases that involve inflammation including ulcerative colitis [73]. 
Increased miR-155 in patients with colitis was shown to decrease suppressor of cytokine signaling 1 
(SOCS1) expression via targeting its 3'UTR [101]. SOCS1 was down regulated in the liver and 
Kupffer cells isolated from ethanol-fed mice suggesting that ethanol-induced miR-155 may negatively 
regulate SOCS1 in the liver [102]. Involvement of SOCS1 in the intestine with ethanol has not been 
determined yet, but, miR-155 targeted and downregulated other inflammatory markers like Src homology 
2-containing inositol phosphatase 1 [73,103]. These observations indicate miR-155 may be involved in 
small bowel inflammation with chronic ethanol exposure [73,103]. 
5.2. microRNAs and Intestinal Tight Junctions in ALD 
Expression of miR-212 was found to be highly abundant in intestine and colon compared to other 
organ like heart, liver, and kidney [104]. Increased levels of miR-212 in the intestine were reported 
with alcohol feeding and this increased miR-212 targets tight junction proteins like Zona Occludens-1 
(ZO-1). Colonic tissues from patients with ALD showed enhanced expression of miR-212 and also 
showed a concomitant decreased ZO-1 protein level. This study suggests that increased miR-212 in the 
small intestine and colon targets tight junction protein and negatively affects intestinal barrier function 
in ALD [104]. Further studies are needed to clarify the mechanism of miR-212 upregulation in the 
intestine and colon of ALD. 
MiR-122 is a liver specific microRNA, but has been found at low levels in non-hepatocytes. TNF- 
was shown to induce the expression of miR-122 in colon-derived Caco-2 cells and enterocytes [105]. 
TNF--induced miR-122 in enterocytes targets 3' UTR of occludin transcript, a tight junction protein [105]. 
Ethanol-fed mice also showed an increase in the expression of miR-122 in the intestine and decreased 
expression of occludin and claudin-1 in the intestine thereby inducing barrier dysfunction [106]. 
Probiotic supplementation of Lactobacillus rhamnosus GG was also shown to protect intestinal barrier 
dysfunction by decreasing the expression of miR-122 in chronic ethanol-fed mice [106]. However, 
bacterial translocation is not unique to ALD; we have shown that liver cirrhosis induces alterations in 
the luminal glycosylation pattern and bacterial overgrowth leading to bacterial translocation [107–109]. 
Whether intestinal bacterial translocation in cirrhotic animals is mediated by miR-122 is unknown. In 
summary, altered microRNAs in the intestine due to ethanol exposure play a role in the pathogenesis 
of ALD by increasing the expression of pro-inflammatory cytokines, and decreasing tight junction 
proteins, favoring intestinal permeability and endotoxemia. 
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6. Brain Injury and microRNAs with Alcohol Consumption 
Brain injury due to alcohol consumption has been well documented. Here we will review the 
important role of microRNAs in alcohol-induced injury to neurons. Ethanol exposure to neurons in 
culture decreased the expression of miR-9, miR-21, miR-153 and miR-335 [110–112]. A recent study 
also revealed that miR-9, miR-29a, miR-29b and miR-133 were decreased in cerebellum granule 
neurons isolated from mice exposed to ethanol. Ethanol decreased the expression of miR-29b in mouse 
cerebrum. Experimental validation confirmed that overexpression of miR-29b protected against 
ethanol-induced neuronal cell apoptosis [113]. Also, ethanol induced the expression of SP1 
transcription factor, murine homolog of human PACT (RAX or dsRNA-binding protein and an 
activator of PKR) and phosphorylation of dsRNA-activated protein kinase (PKR, a serine threonine 
protein kinase) involved in inflammation and neuronal apoptosis [113,114]. Ethanol-induced enhanced 
expression of SP1 and RAX, and increased phospho-PKR were completely blocked in miR-29b 
overexpressing neurons [113]. In addition, ethanol also increased the expression miR-34a that acted as 
pro-apoptotic microRNA [113]. Alcohol increased the expression of miR-9 when analyzed using 
single cell based PCR method [115]. Increased miR-9 in the supraoptic neurons and striatal neurons 
targeted calcium- and voltage-activated potassium channel in the brain [115,116]. 
MiR-132 and miR-212 are encoded by a single gene [103] and the role of miR-212 in the intestine 
barrier dysfunction is discussed in “microRNAs and intestinal tight junctions in ALD” section. MiR-132 
and miR-155 levels were elevated in the brain and livers of mice administered an ethanol-containing 
diet [103]. The mechanism for increased expression of brain miR-132 and -155 was through activation 
of TLR-4 [103]. Pro-inflammatory cytokines like TNF-, MCP1, and IL-1 were upregulated in the 
cerebellum of chronic ethanol fed mice [103]. Ethanol-induced increase in pro-inflammatory cytokines 
expression in the brain was due to an increase in the expression of miR-155. Ethanol did not alter  
brain pro-inflammatory cytokine levels in mice deficient for miR-155 [103]. In summary, levels of 
microRNAs were altered in the brain with ethanol consumption contributing to the brain injury 
observed with alcoholics. 
6.1. Binge Drinking Alters Hippocampal microRNA 
Emerging evidence indicates that a majority of adolescent drinkers consume alcohol in binge  
episodes [117,118]. A recent survey among high school students showed shocking information that 
21% of high school students were binge drinkers in the United States [117]. Adolescent alcohol binge 
drinking was suggested to be associated with long-term memory loss, depression, behavioral problems, 
and poor stress response [117–119]. Rodents exposed to binge ethanol during peripubertal stage exhibit 
damage to hippocampal structure and function and reduced adult neurogenesis resulting in impaired 
memory and neuropsychiatric illness [120]. 
MicroRNAs were suggested to play a role in hippocampal structure and function. Repeated binge 
ethanol exposure in adolescent rats was shown to dramatically increase the expression of miR-10a-5p 
in the hippocampus [119,121,122]. In addition, proteins involved in microRNA processing like Drosha 
and Dicer were also found to be decreased in the ventral and dorsal hippocampus in ethanol exposed 
adolescent rats [119]. Rats exposed to acute-binge ethanol during puberty showed decreased expression 
of miR-26a and miR-495 in the dorsal and ventral hippocampus [119]. The ethanol-induced decrease 
Biomolecules 2015, 5 3319 
 
in miR-26a and miR-495 was suggested to increase target mRNAs, brain-derived neurotropic  
factor (BDNF) and SIRT1, a protein deacetylase [119]. However, increased expression of BDNF  
and SIRT1 in the hippocampus was recently demonstrated to offer protection to hippocampus and  
neurons [123–125]. Further studies are needed to confirm the exact role of miR-10a-5p, miR-26a 
and mi-495 in hippocampal damage during ethanol exposure. 
6.2. Neuronal Damage and microRNA 
The effects of alcoholism on brain white matter shrinkage and neuronal loss in frontal cortex have 
been known for more than three decades [126,127]. Within last few years, a role for microRNAs in 
alcohol-induced brain damage has been proposed and identified. A comprehensive analysis of microRNA 
levels in the frontal cortex of patients with alcoholism showed that 35 microRNAs were upregulated 
including let 7 family members, miR-34c, miR-146a, miR-194, miR-203, and miR-369. This study further 
analyzed mRNA expression [128]. Several of the microRNAs that targeted mRNAs involved cell cycle, 
differentiation, signaling and nervous system development were found to be down regulated in human 
alcoholics [128]. In a human neuroblastoma cell line, in vitro long term ethanol exposure (72 h) results in 
a dramatic increase in miR-302b and miR-497. Both miR-302b and -497 can target BCL2; increased levels 
of miR-497 were shown to be critical for mitochondria-dependent neuronal apoptosis [129]. Increased 
miR-302b was suggested to target cyclin D2 and induced mitochondria-independent apoptosis of neurons 
during alcohol exposure [129]. In addition, the pro-apoptotic microRNA, miR-34a was also shown to be 
upregulated in neurons exposed to ethanol [113,129]. Similarities and differences in these two pioneer 
studies on ethanol-induced brain microRNAs were discussed and reviewed in detail before [130]. 
6.3. Long Noncoding RNA and Ethanol 
Long noncoding RNAs (lncRNAs) range between 200 nucleotides to 100 kb and mostly do not 
have a potential to encode protein [131]. A recent update from LNCipedia, a database for annotated 
lncRNA sequence, shows that there were more than 111,000 human annotated lncRNAs [132]. 
lncRNAs are highly conserved and involved in diverse physiological processes including neuronal 
development [133]. The study of lncRNAs during ethanol toxicity to the brain is in its infant stage. 
However, there was a large increase in the expression of lncRNA, MALAT1 (metastasis associated 
lung adenocarcinoma transcript 1) in the cerebellum, hippocampus and brain stem of human alcoholic 
brain sections obtained from postmortem brain [134]. Increased expression of MALAT1 was also 
observed in rat brain tissues after acute exposure to ethanol [134]. However, the exact mechanism of 
increased MALAT1 expression in human alcoholics was not clear. Oxytocin is known to induce the 
expression of MALAT1 in a neuroblastoma cell line [135], and plasma oxytocin was elevated in human 
alcoholics [136]. Oxytocin levels stayed elevated ever after a month of abstinence [136]. This raises 
the question; does oxytocin play a critical role in the induction of MALAT1 expression? Recently, a 
separate study in patients with alcoholism showed 2–5 fold increased expression of 11 lncRNAs 
(NCRNA00051, NCRNA00256A, NCRNA00256B, NCRNA00250A, NCRNA00245, NCRNA00176, 
NCRNA00116, NCRNA00173, NCRNA00175, NCRNA00230B, and NCRNA00107) [137]. Four other 
lncRNAs and were shown to be downregulated in postmortem prefrontal cortex of human brain [137]. 
The functions of many lncRNAs are still unknown, including the 15 lncRNAs identified in the patients 
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of above described study [137]. Further studies are needed to elucidate the exact function and role of 
these lncRNAs in brain damage observed in human alcoholics. 
6.4. Teratogenic Effect of Ethanol 
Ethanol consumption during pregnancy can be associated with fetal alcohol syndrome. Fetal alcohol 
syndrome is a spectrum of symptoms ranging from abnormal cardiac development, neuronal loss, 
abnormal facial features, growth defect and damage to central nervous system [138]. Ethanol was 
shown to have teratogenic effect on the fetal mouse brain and several microRNAs were reported to be 
involved in this teratogenic effect [139]. Prenatal ethanol exposure was shown to cause mental 
retardation in offspring with impaired locomotor function. Prenatal ethanol exposure was also shown 
to up-regulate several microRNAs (miR-9, miR-10a, miR-10b, miR-30a-3p, miR-145, and miR-152) 
in the fetal brain [139]. Among them, miR-10a and 10b were shown to target homeobox transcription 
factor expression [140,141]. miR-10a and miR-10b also target TBX5, a T-box transcription factor 
involved in embryonic cardiac development [142]. Supplementation of folic acid prevented the 
increase in miR-10a caused due to ethanol in the fetal brain [139]. Folic acid treatment also protects 
cardiac birth defects in mice due to fetal alcohol syndrome [143]. Ethanol ingestion was found to 
dramatically increase retinol and retinoic acid receptor levels in the fetal embryo [144]. Retinoic acid 
receptor antagonist has been shown to inhibit the expression of miR-10a in pancreatic cancer  
cells [140]. Further, ethanol intoxication increases the levels of all-trans retinoic acid levels in the 
embryo [122,144]. Ethanol-induced increase in the levels of all-trans retinoic acid in the brain and 
hippocampus were due to an increase in the expression of retinoic acid synthesizing enzymes [122].  
It is tempting to speculate that increased retinoic acid could be responsible for the observed increase in 
the expression of miR-10a and miR-10b during fetal alcohol syndrome. Further studies are needed to 
confirm this hypothesis of ethanol-induced retinoic acid activating retinoic acid receptor (RAR) to 
enhance miR-10 expression in fetal alcohol syndrome. 
6.5. Maternal Ethanol Consumption 
Maternal ethanol consumption and microRNA changes during fetal alcohol syndrome has been 
extensively studied and reviewed before [5,110–112,121]. Recently, ethanol was shown to decrease the 
expression of miR-335 and miR-9 in the fetal neural stem-cell population and this altered microRNA 
expression was suggested to be due to hypo-methylation was extensive studied and reviewed  
before [112,121,145–148]. Prenatal exposure of alcohol results in life-long problems, e.g., a recent 
study in mice exposed to ethanol before birth showed increased miR-26b in the brain of the next 
generation of mice. Increased miR-26b targets and decreases the levels of cannabinoid receptor 1 
(CB1R) [149]. CB1R is a G-protein coupled receptor and was shown to be abundantly present in the 
mammalian brain. CB1R confers neuroprotection against excitotoxicity by inducing brain-derived 
neurotropic factor (BDNF) via PI3K-protein kinase B(Akt)- mammalian target of Rapamycin complex 
1 axis [150]. Human alcoholics also have shown a decrease in CB1R in their brain as evidenced by 
positron emission tomography analysis. This decreased brain CB1R was not reversible even a month 
after self-withdraw of alcohol consumption [151]. Further studies are needed to confirm whether miR-26 
plays a role in decreasing CB1R levels in the brain of patients with alcoholism or acute alcohol exposure. 
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6.6. Paternal Ethanol Consumption and Epigenetics 
Paternal ethanol exposure was also shown to alter the mental and physical health of an offspring [152]. 
Several studies have confirmed that paternal ethanol consumption results in hyperactivity and impaired 
cognitive skills in children [152,153]. Paternal alcohol consumption and epigenetic mechanisms which 
affects the F1 generation have been recently reviewed [153–155]. Paternal ethanol consumption was 
shown to decrease cytosine methyltransferase transcript levels in sperm [156]. Also, mammalian  
sperm-derived miR-34c has been shown to be critical for the zygote’s first cell division by targeting 
BCL-2 protein expression [157]. Here BCL-2 was suggested to have an anti-proliferative function by 
negatively regulating cyclin-dependent kinase inhibitor, p27 [157,158]. Paternal alcohol consumption 
and microRNA changes in the sperm have not been studied yet. However, exposure of male mice to 
stress or paternal stress increases several sperm microRNAs such as, miR-29c, miR-30a, miR-30c,  
miR-32, miR-193, miR-204, miR-375, miR-532-3p and miR-698 [159]. Similarly, high fat diet-induced 
obese male mice also showed global hypomethylation of sperm DNA and exhibited altered microRNAs 
levels [160,161]. Alcohol-induced changes in paternal microRNAs should be investigated. 
7. Alcoholic Cardiomyopathy 
Alcohol consumption also affects other vital organ like heart. Epidemiological evidence suggests 
that heavy drinking predisposes to the development of cardiac arrhythmia [162], cardiomyopathy 
and/or even sudden cardiac death [163–166]. Chronic alcohol intake results in increased cardiac 
remodeling by reducing gap junction proteins like connexin 43, decreased size of cardiomyocytes  
and altered myocardial conduction. Chronic alcohol-fed mice displayed mitochondrial damage in 
cardiomyocytes [167]. Further, acute ethanol exposure was also shown to decrease atrial current 
densities [168]. MicroRNAs play an important role in cardiac function and ageing, e.g., miR-34a was 
shown to be upregulated in the aged heart, contributing to cardiomyocyte cell death which results in an 
age-related decrease in cardiac function [169]. Additionally, ethanol feeding increased the levels of 
beclin 1, an autophagic marker and triggered the formation of autophagosomes in cardiomyocytes and 
results in myocardial contractile dysfunction through autophagy [170]. Similarly, ethanol exposure 
decreased the expression of miR-30a, a target of beclin 1 in cardiomyocytes [170]. A recent study 
profiled the microRNA signature in plasma from patients with alcoholic cardiomyopathy compared to 
a healthy population [171]. Patients with alcoholic cardiomyopathy showed changes in several 
microRNAs (miR-138, miR-485-5p, miR-506, miR-512-5p, miR-548-3p, and miR-4262) and suggested 
to be involved in the development of cardiac dysfunction [171]. Among these microRNAs, miR-138 
was recommended as a biomarker for early diagnosis of alcoholic cardiomyopathy. Further studies are 
needed to elucidate the functional role of these microRNAs and to confirm that they are indeed from 
cardiac tissue. 
Role of microRNAs in Alcohol-Induced Muscle Injury 
Chronic alcoholism also contributes to muscle myopathy and muscle weakness termed as alcoholic 
myopathy. Interestingly, females are more susceptible to alcoholic myopathy and cardiomyopathy  
than male counterparts [172,173]. Alcoholic myopathy was shown to be highly associated with the 
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malnutrition not with the severity of liver disease, duration of alcohol abstinence or neuropathy. 
Ethanol inhibits muscle function by blocking muscle membrane channels, sodium, potassium pumps 
and impairs muscle mitochondrial function [174,175]. A recent study in rats fed with ad lib liquid 
6.7% ethanol-containing diet for 3 weeks showed increased miR-127, miR-136, miR-378 and miR-150.3p. 
Mir-92b, miR-96-5p, and miR-192-5p were downregulated in muscle with ethanol feeding. However 
the main objective of this study was to compare brain and serum microRNA [176]. Further studies  
are needed to determine the exact functions of these altered microRNAs in muscle injury with 
ethanol consumption. 
8. Conclusions 
Table 1. Ethanol exposure induces the levels of microRNAs in various organs. Altered 
microRNAs were listed by affected organs, and their known target proteins were included 
in this table. 
Affected Organ Upregulated microRNA Targets References 
Pancreas 
miR-21 Connective tissue growth factor [18,19] 
miR-199a-3p [18] 
miR-211 [18] 
Liver 
miR-21 Btg2, IL-6, STAT3 [24,36,45–47] 
miR-33 VLDL [37,47] 
miR-34a Caspase-2, SIRT1 [24] 
miR-132 p65 subunit of NFkB [34] 
miR-137 [24] 
miR-155 TNF-, MCL1,SIRT1 [25,32,35] 
miR-185 [84] 
miR-199a-3p [84] 
miR-214 [84] 
miR-217 SIRT1, Lipin-1 [39] 
miR-320 [23] 
miR-409-5p [24] 
miR-486 [23] 
miR-490 [84] 
miR-509-3p [24] 
miR-705 [23] 
miR-882 [24] 
miR-1224 [23] 
Intestine 
miR-122 TNF- [71,72] 
miR-155 
FASLG, DR5, TNF-, Regb, Src homology 
domain 2-containing inosital phosphatase 
[36,67–69] 
miR-212 ZO-1 [70] 
Circulation 
miR-122 TLR4, NADPH Oxidase [82] 
miR-155 [36,50,78,82] 
miR-185 [84] 
miR-199a-3p [84] 
miR-214 [84] 
miR-490 [84] 
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Table 1. Cont. 
Affected Organ Upregulated microRNA Targets References 
Brain 
Let 7 Family members [109] 
miR-9 [120] 
miR-10a, miR-10b TBX5, Homeobox [97,99,120–123] 
miR-21 
miR-26b CB1R [130] 
miR-29b SP1, RAX, Phospho-PKR [91] 
miR-30a-3p [120] 
miR-34a [110] 
miR-145 [120] 
miR-146a [106] 
miR-132 [69] 
miR-152 [120] 
miR-155 TNF- [69] 
miR-194 [106] 
miR-203 [106] 
miR-302b Bcl2, Cyclin D2 [110] 
miR-369 [106] 
miR-497 Bcl2 [110] 
Heart 
miR-138 [149] 
miR-485-5p [149] 
miR-506 [149] 
miR-512-5p [149] 
miR-548-3p [149] 
miR-4262 [149] 
Ethanol exposure alters the expression of microRNAs to fine-tune protein levels that are involved in 
different signaling pathways. We presented evidence for altered microRNA expression in all the organs 
reported suggesting that microRNA acts as an important mediator of alcohol-induced multi-organ 
damage. Ethanol-induced upregulated microRNA in vital organs and circulation were listed in Table 1 
and downregulated microRNAs were listed in Table 2. Some of the microRNAs were similarly altered 
in two different organs and functions similarly. For example, miR-132 and miR-155 were elevated in 
liver, intestine and brain for a similar function to induce pro-inflammatory cytokines. Interestingly, 
microRNAs like miR-34a were elevated and exert dual role with ethanol exposure in two different 
organs. Increased miR-34a was shown to target caspase-2 and SIRT1 and acts as an anti-apoptotic 
signal in the liver with ethanol exposure. Whereas in the brain, increased miR-34a has a pro-apoptotic 
function. These observations suggest that more studies are needed to elucidate the mechanism behind 
this discrepancy. In addition, bioinformatics analysis of microRNAs suggests large number of target 
genes and it is important that these targets have been validated experimentally before drawing any 
conclusion. For example, ectopic overexpression of biotinylated miR-34a has been shown to target  
982 genes [59]. However, how many of these miR-34a targets can be regulated by the endogenous 
levels of miR-34a remain unanswered [59]. Additional, microRNA target validation using RT-qPCR is 
necessary to confirm bioinformatics analysis or microarray results. In conclusion, we have presented 
evidence for the role of microRNAs in ethanol-induced multi-organ damage to pancreas, bone marrow, 
liver, intestine, brain, heart and muscle. Further, we have also presented evidence for ethanol as an 
epigenetic modulator during paternal and maternal ethanol consumption. 
Biomolecules 2015, 5 3324 
 
Table 2. Downregulated microRNAs with ethanol consumption. Several microRNAs  
were found to be decreased in pancreas, liver, brain and heart with ethanol exposure. 
Downregulated microRNAs were listed by affected organs, and their known target proteins 
were included with references. 
Affected Organ Downregulated microRNA Targets References 
Pancreas 
miR-148a [18] 
miR-802 [18] 
Liver 
Let-7a [24] 
Let-7b [24] 
Let-7g [24] 
miR-27b [23] 
miR-122 [24] 
miR-127 [24] 
miR-27b [23] 
miR-181a,b [24] 
miR-182 [23] 
miR-183 [23] 
miR-192 [24] 
miR-199a-3p Endothelin-1, HIF1- [23,25,32] 
miR-200a [23] 
miR-214 [23] 
miR-322 [23] 
miR-871 [24] 
Brain 
miR-9 [94,123–126] 
miR-21 [79–81] 
miR-26a BDNF, SIRT1 [97] 
miR-29a [91] 
miR-29b [91] 
miR-133 [91] 
miR-153 [79–81] 
miR-335 [126] 
miR-495 BDNF, SIRT1 [97] 
Heart miR-30a Beclin 1 [148] 
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